Crossmark

Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo

Crossref DOI link: https://doi.org/10.1186/s12885-016-2744-9

Published Online: 2016-08-31

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Harima, Hirofumi

Kaino, Seiji

Takami, Taro

Shinoda, Shuhei

Matsumoto, Toshihiko

Fujisawa, Koichi

Yamamoto, Naoki

Yamasaki, Takahiro

Sakaida, Isao
Funding

Funding for this research was provided by:

Yamaguchi University (the Strategic Research Promotion Program)

Yamaguchi University Hospital (the Translational Research Program)

Pancreas Research Foundation of Japan (the Pancreatic Disease Research Award)
License Information

License valid from 2016-08-31